○Shunta Okabe¹, Keishun Iwao¹, Tesshu Hori², Shouhei Ikuta³, Satoko Hattori⁴, Keizou Takao^5,6,7, Tuyoshi Miyakawa⁴, Chieko Koike^1,2,3,8 (1. College of Pharmaceutical Science, Ritsumeikan Univ., 2. Graduate school of Pharmaceutical Science, Ritsumeikan Univ., 3. Graduate school of life Sciences, Ritsumeikan Univ., 4. Center for Medical Science, Fujita Health Univ., 5. Graduate school of Medicine and Pharmaceutical Science, Toyama Univ., 6. Administration Center for Promotion of Research, Organization for Promotion of Research, Toyama Univ., 7. Research Center for Idling Brain Science, Toyama Univ., 8. Center for Systems Vision Science, Research Organization for Science and Technology, Ritsumeikan Univ.)

○keishun iwao¹, Shunta Okabe¹, Tesshu Hori², Shoheiei Ikuta³, Satoko Hattori⁴, Keizo Takao^5,6,7, Tsuyoshi Miyakawa⁴, Chieko Koike^1,2,3,8 (1. College of Pharmaceutical Science, Ritsumeikan Univ., 2. Graduate school of Pharmaceutical Science, Ritsumeikan Univ., 3. Graduate school of life Sciences, Ritsumeikan Univ., 4. Center for Medical Science, Fujita Health Univ., 5. Graduate school of Medicine and Pharmaceutical Science, Toyama Univ., 6. Administration Center for Promotion of Research, Organization for Promotion of Research, Toyama Univ., 7. Research Center for Idling Brain Science, Toyama Univ., 8. Center for Systems Vision Science, Research Organization for Science and Technology, Ritsumeikan Univ.)

○Rin Sawada¹, Akiko Ueno², Yusuke Inoue¹, Chiseto Maejima³, Yoshimi Takai⁴, Jun Miyoshi⁵, Chieko Koike^1,2,3,6 (1. Grad. Sch. Pharm., Ritsumeikan Univ., 2. R-GIRO., Ritsumeikan Univ., 3. Col. Pharm. Sci., Ritsumeikan Univ. , 4. Grad. Sch. Med., Kobe Univ., 5. Osaka Medical Center for Cancer and Cardiovascular Diseases, 6. Center for Systems Vision Science, Research Organization of Science and Technology, Ritsumeikan Univ.)

○Naho Baba¹, Rin Sawada², Peiyu Zhang², Akiko Ueno³, Fumio Nakamura⁴, Masayoshi Mishina⁵, Chieko Koike^1,2,3,6 (1. Col. Pharm. Sci., Ritsumeikan Univ., 2. Grad. Sch. Pharm. Sci., Ritsumeikan Univ., 3. R-GIRO, Ritsumeikan Univ. , 4. Sch. Med., Tokyo Women’s Medical Univ. , 5. Res. Org. Sci. Tech., Ritsumeikan Univ., 6. CSVS., Ritsumeikan Univ.)

○Toshiki Maeda¹, Hironobu Shuto^2,3, Takesi Matsuyama³, Chieko Koike^1,2,4,5 (1. College of Pharmaceutical Science, Ritsumeikan Univ., 2. Graduate school of Pharmaceutical Science, Ritsumeikan Univ., 3. Vision Care Inc, 4. Graduate school of life Sciences, Ritsumeikan Univ., 5. Center for Systems Vision Science, Research Organization for Science and Technology, Ritsumeikan Univ.)

○Riho Komuro¹, Yuka Honda¹, Motoaki Yanaizu¹, Masami Nagahama¹, Yoshihiro Kino¹ (1. Meiji Pharmaceutical Univ.)

○Nami Tsuchiya¹, Motoaki Yanaizu¹, Makoto Araki¹, Kenji Kontani¹, Yoshihiro Kino¹ (1. Meiji Pharmaceutical Univ.)

○Ruri Kojima¹, Masaki Ishii¹, Shinya Ohata¹ (1. Faculty. Sch. Pharm. Sci., Musashino Univ.)

○Toshiyuki Yamada¹, Aemi Taguchi¹, Haruka Fushimi¹, Taiga Kurihara¹, Hiroyuki Yamamoto¹ (1. Nihon Pharm. Univ. , Dept. of Microbiol. and Mol. Cell Biol.)

○Shotaro Kawano¹, Tomohiro Takada¹, Yukiko Ayusawa¹, Hotaka Fukushima¹, Daiki Miura¹, Ryota Hashimoto², Hitoshi Hashimoto^2,3,4,5,6,7, Takanobu Nakazawa^1,2 (1. Grad. Sch. of Life Sci., Tokyo Univ. Agr., 2. Dept. Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, 3. Grad. Sch. Pharmaceut. Sci., Osaka Univ. , 4. United Grad. Sch. Child Dev., Osaka Univ. , 5. Div. Biosci., Inst. Datability Sci., Osaka Univ., 6. Transdimensional Life Imaging Div., Inst. Open Transdiscip. Res. Initiatives, Osaka Univ., 7. Grad. Sch. Med., Osaka Univ.)

○Hiroyuki Mizuno¹, Yuji Ikegaya^1,2 (1. Grad Sch Pharmaceut Sci, Univ Tokyo, 2. Inst AI Beyond, Univ Tokyo)

○Tomohiro Takada¹, Shotaro Kawano¹, Yukiko Ayusawa¹, Hotaka Fukushima¹, Daiki Miura¹, Ryota Hashimoto², Hitoshi Hashimoto^2,3,4,5,6,7, Takanobu Nakazawa^1,2 (1. Grad. Sch. of Life Sci., Tokyo Univ. Agr., 2. Dept. Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, 3. Grad. Sch. Pharmaceut. Sci., Osaka Univ., 4. United Grad. Sch. Child Dev., Osaka Univ., 5. Div. Biosci., Inst. Datability Sci., Osaka Univ., 6. Transdimensional Life Imaging Div., Inst. Open Transdiscip. Res. Initiatives, Osaka Univ., 7. Grad. Sch. Med., Osaka Univ.)

○Kohei Arimura¹, Hironori Izumi², Hisashi Mori², Shin'ya Ohmori³, Satoru Mitazaki¹, Mamoru Fukuchi¹ (1. Mol. Neurosci., Fac. Pharm., Takasaki Univ. of Hlth & Welfare, 2. Fac. Med., Univ. of Toyama, 3. Fac. Pharm., Takasaki Univ. of Hlth & Welfare)

○Hibiki Nakasone¹, Yuka Matsuoka¹, Rento Kasahara¹, Mamoru Fukuchi¹ (1. Fac. Pharm., Takasaki Univ. of Hlth & Welfare)

○Torashige Sono¹, Kaneyasu Nishimura^1,3, Takashi Ohgita², Haruka Ito¹, Hiroyuki Saito², Kazuyuki Takata¹ (1. Div. Integ. Pharm. Sci., Kyoto Pharm. Univ., 2. Dept. Biophys. Chem., Kyoto Pharm. Univ., 3. Grad. Sch. Brain Sci., Doshisha Univ.)

○Akari Okuyama¹, Yuya Akimoto¹, Hotaka Fukusima¹, Daiki Miura¹, Takanobu Nakazawa¹ (1. Grad. Sch. of Life Sci., Tokyo Univ. Agr.)

○Yuya Akimoto¹, Masayuki Baba², Hotaka Fukushima¹, Daiki Miura¹, Hitoshi Hashimoto^2,3,4,5,6,7, Ryota Hashimoto³, Takanobu Nakazawa^1,3 (1. Grad. Sch. of Life Sci., Tokyo Univ. Agr., 2. Grad. Sch. Pharmaceut. Sci., Osaka Univ., 3. Dept. Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, 4. United Grad. Sch. Child Dev., Osaka Univ., 5. Div. Biosci., Inst. Datability Sci., Osaka Univ., 6. Transdimensional Life Imaging Div., Inst. Open Transdiscip. Res. Initiatives, Osaka Univ., 7. Grad. Sch. Med., Osaka Univ.)

○Yoshikazu Morishita¹, Ayame Kubo², Kyoka Nishimura², Rintaro Shimizume^1,2, Yuki Takamura^1,2, Yuto Yokoi¹, Natsuko Hitora-Imamura², Masabumi Minami², Hiroshi Nomura^1,2 (1. Graduate School of Medical sciences, Nagoya City University, 2. Graduate School of Pharmaceutical Sciences, Hokkaido University)

○Mika Matsumura^1,2, Narumi Taketomi¹, Shingo Saio^1,2, Kanna Konishi^1,2, Tadashi Okamoto², Masamitsu Ichihashi², Ken-ichi Mizutani¹ (1. Grad. Sch. Pharm. Sci. Kobe Gakuin Univ., 2. Sch. Pharm. Sci. Kobe Gakuin Univ.)

○Tohru Yamamoto¹, Daiki Ojima¹, Atsushi Tada¹, Naohiro Kurokawa², Hiroo Takahashi¹, Takashi Tominaga², Kishimoto Yasushi^2,3 (1. Fac. Med., Kagawa Univ., 2. Fac. Kagawa Pharm. Tokushima Bunri Univ., 3. Fac. Pharm. Teikyo Univ.)

○Kazuya Yoshioka¹, Taiki Okada¹, Miku Tanabe¹, Daiki Miura¹, Hotaka Fukushima¹, Rie Ishikawa², Satoshi Kida², Takanobu Nakazawa¹ (1. Graduate School of Life Sciences, Tokyo University of Agriculture, 2. Graduate School of Agriculture and Life Sciences, The University of Tokyo)

○Kao Hashimoto^1,2, Yasuyuki Nagumo², Keita Iio^2,3, Yuki Saito^1,2, Yukiko Ishikawa², Noriki Kutsumura^1,2,3, Takeshi Sakurai^1,2, Masashi Yanagisawa^1,2, Tsuyoshi Saitoh^1,2, Hiroshi Nagase^2,3 (1. Grad. Sch. Comp Hum. Sci., Univ. Tsukuba, 2. IIIS, Univ. Tsukuba, 3. Grad. Sch. Pure Appl. Sci., Univ. Tsukuba)

○Kanna Konishi^1,2, Yoshimi Abe¹, Sakiho Koyama¹, Shingo Saio¹, Teruaki Masutani³, Iddamalgoda Arunasiri³, Tadashi Okamoto², Masamitsu Ichihashi², Ken-ichi Mizutani¹ (1. Grad. Sch. Pharm. Sci., Kobe Gakuin Univ., 2. Sch. Pharm. Sci., Kobe Gakuin Univ., 3. Research&Development,Ichimaru Pharcos Co,Ltd,)

○Momoko Miyazawa¹, Ayumi Nakashima¹, Toshiharu suzuki², Hidenori Taru² (1. Fac. Pharm. Sci., Univ. Hokkaido, 2. Grad. Sch. Pharm. Sci., Univ. Hokkaido)

○Mami Hino¹, Kanako Ichihara¹, Kouki Fujinaga¹, Syou Kataoka¹, Masayuki Nakanishi¹, Hiroshi Nomoto¹ (1. Coll. Pharm. Sci., Matsuyama Univ.)

○Hiroo Takahashi¹, Daiki Ojima¹, Atsushi Tada¹, Akio Tsuboi², Tohru Yamamoto¹ (1. Faculty of Med., Kagawa Univ., 2. Grad. Sch. Front. Biosci., Osaka Univ.)

○Ayuko Masaki¹, Saki Egashira¹, Rie Mukai¹, Kana Kumagai¹, Takafumi Nakano², Keiichi Irie¹, Yuta Yamashita¹, Kazunori Sano¹, Tomomitsu Satho¹, Kenichi Mishima¹ (1. Dept.pharmacol.Fukuoka Univ, 2. Dept.pharm.Fukuoka Univ.Hosp.)

○Saki Egashira¹, Ayuko Masaki¹, Rie Mukai¹, Takafumi Nakano^1,2, Masato Hosokawa¹, Fuyuki Kametani³, Keiichi Irie¹, Tomomitsu Satho¹, Yuta Yamashita¹, Kazunori Sano¹, Kenichi Mishima¹ (1. Dept.pharmacol.Fukuoka Univ., 2. Dept.pharm.Fukuoka Univ.Hosp., 3. Tokyo metroplitan institute of Medical Sci.)

○Kazuna Kikkawa¹, Masahiro Fujimuro¹, Yuichi Sekine¹ (1. Kyoto Pharm. Univ.)

○Yuka Nakamura¹, Yuki Kitanishi², Daichi Kawaguchi², Yukiko Gotoh² (1. Fac. of Pharm. Sci., Univ. of Tokyo, 2. Grad. Sch. Pharm. Sci., Univ. of Tokyo)

○Mamoru Matsubara¹, Harukazu Fukami² (1. Pharm. Sci., Gifu Univ. Med. Sci., 2. Bioenv. Sci. Kyoto Univ. Adv. Sci.)

○ikumi mizuno¹, shingo matsuda^1,2, yoshimi ogawa¹, akihiro mizutani¹ (1. Grad. Sch. Pharmaceutical., Shouwa Pharmaceutical Univ., 2. Grad. Sch. Medicine., Chiba Univ.)

○Yasuaki Takahara¹, Naomi Hasegawa³, Koichi Hamada², Akihiro Mizutani² (1. Grad. Sch. Pharm Sci., Showa Pharm. Univ., 2. Showa Pharm. Univ., 3. Natl. Inst. of Ment. Health., Natl. Ctr. of Neurol. & Psychiat.)

○Kenji Senoo¹, Junya Onodera¹, Akira Murakami¹, Koki Okabe¹, Shibasaki Koji², Yuji Ikegaya^1,3, Ryuta Koyama^1,3 (1. Grad. Sch. Pharm. Sci., Univ Tokyo, 2. Grad. Sch. of Human Health Sci., Univ Nagasaki, 3. Inst AI Beyond, Univ Tokyo)